Medicare to cover weight loss drugs in pilot program: How you could save on treatment

A new Medicare pilot program will allow certain plans to cover approved GLP-1 weight loss medications for eligible beneficiaries, expanding access beyond previous coverage limited to diabetes and cardiovascular conditions. The program targets obesity, affecting over 40% of U.S. adults, aiming to improve health outcomes and reduce long-term costs. Eligibility depends on plan participation and medical criteria, with some cost-sharing possible. The initiative could influence future Medicare obesity treatment policies.